CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 165 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $48,000 | -97.9% | 26,841 | -93.3% | 0.00% | -100.0% |
Q3 2020 | $2,332,000 | +2889.7% | 400,000 | +3357.5% | 0.02% | +1600.0% |
Q2 2020 | $78,000 | -98.7% | 11,569 | -97.1% | 0.00% | -97.3% |
Q2 2019 | $5,843,000 | -44.5% | 392,919 | -7.4% | 0.04% | -47.1% |
Q1 2019 | $10,526,000 | -24.2% | 424,099 | -45.1% | 0.07% | -30.0% |
Q4 2018 | $13,878,000 | -35.9% | 772,718 | +10.5% | 0.10% | +1.0% |
Q3 2018 | $21,653,000 | -11.5% | 699,066 | +30.0% | 0.10% | -11.6% |
Q2 2018 | $24,455,000 | -24.0% | 537,813 | -11.7% | 0.11% | -16.4% |
Q1 2018 | $32,164,000 | +7.9% | 609,166 | +39.0% | 0.13% | +42.6% |
Q4 2017 | $29,801,000 | -57.1% | 438,245 | -48.1% | 0.09% | -65.4% |
Q3 2017 | $69,520,000 | +21.5% | 843,688 | +38.0% | 0.27% | +15.3% |
Q2 2017 | $57,231,000 | -24.1% | 611,251 | -48.4% | 0.24% | -33.0% |
Q1 2017 | $75,435,000 | +132.5% | 1,184,771 | +62.2% | 0.35% | +102.3% |
Q4 2016 | $32,451,000 | -36.2% | 730,539 | -48.2% | 0.17% | -40.8% |
Q3 2016 | $50,860,000 | +4842.7% | 1,410,826 | +1781.1% | 0.29% | +4100.0% |
Q2 2016 | $1,029,000 | -96.8% | 75,000 | -91.8% | 0.01% | -96.8% |
Q4 2015 | $31,857,000 | -28.3% | 910,204 | +88.3% | 0.22% | -32.6% |
Q3 2015 | $44,443,000 | +667.4% | 483,281 | +633.4% | 0.33% | +811.1% |
Q2 2015 | $5,791,000 | -64.1% | 65,900 | -69.7% | 0.04% | -72.3% |
Q1 2015 | $16,139,000 | +114.1% | 217,414 | +30.8% | 0.13% | +124.1% |
Q3 2014 | $7,538,000 | +177.3% | 166,176 | +153.2% | 0.06% | +87.1% |
Q2 2014 | $2,718,000 | – | 65,643 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |